Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michael Knitz

Concepts (94)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
13
2024
563
2.370
Why?
T-Lymphocytes, Regulatory
5
2026
415
0.900
Why?
Immunotherapy
5
2025
671
0.680
Why?
Radiation Tolerance
1
2021
101
0.630
Why?
Tumor Microenvironment
9
2025
747
0.600
Why?
Carcinoma, Pancreatic Ductal
5
2025
297
0.590
Why?
Ephrin-B2
4
2024
45
0.580
Why?
Antineoplastic Agents, Immunological
1
2021
200
0.550
Why?
Receptor, EphB4
3
2024
33
0.550
Why?
Dendritic Cells
1
2021
509
0.510
Why?
Papillomavirus Infections
1
2021
345
0.510
Why?
Drug Resistance, Neoplasm
1
2021
893
0.440
Why?
Pancreatic Neoplasms
5
2025
944
0.420
Why?
Cell Line, Tumor
6
2025
3545
0.300
Why?
Mice
16
2026
18297
0.290
Why?
CD8-Positive T-Lymphocytes
5
2026
931
0.280
Why?
Interleukin-2 Receptor alpha Subunit
3
2023
82
0.260
Why?
Hepatocyte Nuclear Factor 1-alpha
1
2026
20
0.230
Why?
Interleukin-15
1
2026
96
0.220
Why?
Interleukin-2
2
2023
434
0.220
Why?
Adenocarcinoma
2
2023
927
0.220
Why?
Animals
16
2026
38107
0.210
Why?
PPAR alpha
1
2024
56
0.200
Why?
Oleic Acid
1
2024
40
0.200
Why?
Calcitonin Gene-Related Peptide
1
2024
39
0.200
Why?
Interleukin-7
1
2024
66
0.200
Why?
Spiral Cone-Beam Computed Tomography
1
2023
5
0.200
Why?
STAT3 Transcription Factor
2
2022
214
0.190
Why?
Epithelial-Mesenchymal Transition
2
2024
219
0.190
Why?
Tumor Burden
2
2021
326
0.190
Why?
Mice, Knockout
4
2026
3125
0.180
Why?
Vasculitis
1
2023
69
0.180
Why?
Sentinel Lymph Node
1
2022
49
0.180
Why?
Radioimmunotherapy
1
2021
25
0.170
Why?
Combined Modality Therapy
2
2022
1271
0.170
Why?
STAT1 Transcription Factor
1
2021
68
0.170
Why?
Mice, Inbred BALB C
2
2021
1244
0.170
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
1
2021
23
0.170
Why?
ADAM10 Protein
1
2021
29
0.160
Why?
Basic-Leucine Zipper Transcription Factors
1
2021
43
0.160
Why?
Lymphocyte Depletion
1
2021
135
0.160
Why?
Receptor, Anaphylatoxin C5a
1
2021
35
0.160
Why?
Gamma Rays
1
2021
56
0.160
Why?
Amyloid Precursor Protein Secretases
1
2021
80
0.160
Why?
Receptors, Complement
1
2021
126
0.160
Why?
Complement Inactivating Agents
1
2021
78
0.150
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
156
0.150
Why?
Radiation Injuries
1
2021
149
0.150
Why?
Cell Proliferation
3
2021
2502
0.140
Why?
Mice, Inbred C57BL
4
2026
6034
0.140
Why?
Fibrosis
1
2021
568
0.140
Why?
Membrane Proteins
2
2021
1130
0.130
Why?
Repressor Proteins
1
2021
430
0.130
Why?
Glioblastoma
1
2020
350
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2020
1432
0.100
Why?
Biomarkers, Tumor
1
2020
1339
0.090
Why?
T-Lymphocytes
1
2021
2012
0.090
Why?
Phenotype
1
2021
3206
0.090
Why?
Humans
16
2026
146342
0.090
Why?
Tumor Cells, Cultured
2
2021
882
0.070
Why?
Xenograft Model Antitumor Assays
2
2021
930
0.060
Why?
Cell Movement
2
2021
951
0.060
Why?
Survival Rate
2
2021
2092
0.060
Why?
Fenofibrate
1
2024
28
0.050
Why?
Cone-Beam Computed Tomography
1
2023
32
0.050
Why?
CA-19-9 Antigen
1
2023
36
0.050
Why?
T-Lymphocytes, Cytotoxic
1
2023
180
0.050
Why?
Neoplasm Metastasis
1
2024
693
0.040
Why?
Apoptosis
2
2021
2439
0.040
Why?
Prognosis
2
2021
4351
0.040
Why?
Lymph Node Excision
1
2022
174
0.040
Why?
Programmed Cell Death 1 Receptor
1
2023
268
0.040
Why?
Fatty Acids
1
2024
460
0.040
Why?
Forkhead Transcription Factors
1
2021
209
0.040
Why?
Complement C3
1
2021
195
0.040
Why?
Neoadjuvant Therapy
1
2023
475
0.040
Why?
Signal Transduction
2
2024
5246
0.040
Why?
Dexamethasone
1
2021
368
0.030
Why?
Neoplasm Invasiveness
1
2020
504
0.030
Why?
Mice, Nude
1
2020
668
0.030
Why?
Killer Cells, Natural
1
2021
481
0.030
Why?
Software
1
2023
676
0.030
Why?
CD4-Positive T-Lymphocytes
1
2024
1150
0.030
Why?
Phosphorylation
1
2020
1724
0.030
Why?
Immunity, Innate
1
2021
844
0.030
Why?
Reproducibility of Results
1
2023
3416
0.030
Why?
Disease Progression
1
2022
2867
0.030
Why?
Disease Models, Animal
1
2024
4580
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2023
1998
0.020
Why?
Inflammation
1
2023
2919
0.020
Why?
Time Factors
1
2021
7109
0.020
Why?
Female
3
2025
79499
0.020
Why?
Treatment Outcome
1
2023
11821
0.020
Why?
Retrospective Studies
1
2023
17438
0.010
Why?
Knitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)